<DOC>
	<DOC>NCT00681759</DOC>
	<brief_summary>The purpose of this study is to investigate the burden of upper gastrointestinal symptoms in patients with cardiovascular disease taking low dose aspirin</brief_summary>
	<brief_title>An Observational Study of Burden of Upper GI-Symptoms in CV Risk Patients</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Provision of signed written inform consent. Physician prescribed or recommended daily intake of Low Dose Aspirin (LDA) (75325 mg daily) for cardiovascular disease prevention within the past 12 months. Established cardiovascular disease, such as CAD (CoronaryArtery Disease), previous TIA (Transient Ischemic Attack), ischemic stroke or subjects with known risk factors for cardiovascular disease without having experienced cardiovascular events Need for concomitant treatment with a nonASA NSAID (Nonsteroidal Antiinflammatory Drugs) including acyclooxygenase2 (COX2) selective NSAID. Occasional use of up to 1 day/week is allowed.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Low Dose Aspirin (LDA)</keyword>
	<keyword>Cardiovascular disease</keyword>
	<keyword>Low Dose Aspirin (LDA) use in in subjects with cardiovascular risk or disease</keyword>
</DOC>